These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8671224)

  • 21. The effect of intrauterine levonorgestrel use on the expression of c-JUN, oestrogen receptors, progesterone receptors and Ki-67 in human endometrium.
    Salmi A; Pakarinen P; Peltola AM; Rutanen EM
    Mol Hum Reprod; 1998 Dec; 4(12):1110-5. PubMed ID: 9872360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of progesterone administered by nasal spray on the human postmenopausal endometrium.
    Cicinelli E; Petruzzi D; Scorcia P; Resta L
    Maturitas; 1993 Dec; 18(1):65-72. PubMed ID: 8107618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A; Milkov V
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms.
    Neulen J; Williams RF; Breckwoldt M; Chwalisz K; Baulieu EE; Hodgen GD
    Hum Reprod; 1996 Jul; 11(7):1533-7. PubMed ID: 8671500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium.
    Bayard F; Damilano S; Robel P; Baulieu EE
    J Clin Endocrinol Metab; 1978 Apr; 46(4):635-48. PubMed ID: 755048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of endometrial endothelial cell proliferation by oestrogen and progesterone in the ovariectomized mouse.
    Heryanto B; Rogers PA
    Reproduction; 2002 Jan; 123(1):107-13. PubMed ID: 11869192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of tamoxifen alone and in combination with RU 486 on the endometrium in the mid-luteal phase.
    Swahn ML; Bygdeman M; Seppälä M; Johannisson E; Cekan S
    Hum Reprod; 1993 Feb; 8(2):193-200. PubMed ID: 8473418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of drospirenone/estradiol on steroid receptors and Bcl-2 in the postmenopausal endometrium.
    Lima SM; Reis BF; Yamada SS; Postigo S; Grande RM; Botogoski SR; Campaner AB; Hueb CK; Galvão MA
    Climacteric; 2011 Oct; 14(5):551-7. PubMed ID: 21469974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrial response in post-menopausal women during treatment with percutaneous 17 beta-oestradiol opposed by oral progesterone.
    Holst J; Cajander S; von Schoultz B
    Maturitas; 1986 Oct; 8(3):201-7. PubMed ID: 3784916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept.
    Fatemi HM; Bourgain C; Donoso P; Blockeel C; Papanikolaou EG; Popovic-Todorovic B; Devroey P
    Hum Reprod; 2007 May; 22(5):1260-3. PubMed ID: 17227809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience with a 'physiological' steroid replacement regimen for the establishment of a receptive endometrium in women with premature ovarian failure.
    Critchley HO; Buckley CH; Anderson DC
    Br J Obstet Gynaecol; 1990 Sep; 97(9):804-10. PubMed ID: 2242365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical analysis of oestrogen and progesterone receptors in endometriotic tissue and endometrium.
    Bergqvist A; Ljungberg O; Skoog L
    Hum Reprod; 1993 Nov; 8(11):1915-22. PubMed ID: 8288760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Influence of Intravaginal Gestagens Treatment on the Morphological Features and Endometrial Steroid Hormone Receptors Content during Anestrus Type II in Dairy Cattle.
    Trela M; Witkowska-Piłaszewicz O; Domańska D; Kaczmarek MM; Pawliński B; Gajewski Z; Domino M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimal dose combined hormonal replacement therapy for menopausal women.
    Wren BG
    Med J Aust; 1981 Apr; 1(7):353-6. PubMed ID: 7242418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen action in the reproductive tract of rhesus monkeys during antiprogestin treatment.
    Slayden OD; Hirst JJ; Brenner RM
    Endocrinology; 1993 Apr; 132(4):1845-56. PubMed ID: 8462480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose dependent effects of oral progesterone on the oestrogenised postmenopausal endometrium.
    Lane G; Siddle NC; Ryder TA; Pryse-Davies J; King RJ; Whitehead MI
    Br Med J (Clin Res Ed); 1983 Oct; 287(6401):1241-5. PubMed ID: 6315123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device: Can Cu-T prevent endometrial cancer?
    Guleria K; Agarwal N; Mishra K; Gulati R; Mehendiratta A
    J Obstet Gynaecol Res; 2004 Jun; 30(3):181-7. PubMed ID: 15210039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic progesterone antagonist-estradiol therapy suppresses breakthrough bleeding and endometrial proliferation in a menopausal macaque model.
    Slayden OD; Zelinski MB; Chwalisz K; Hess-Stumpp H; Brenner RM
    Hum Reprod; 2006 Dec; 21(12):3081-90. PubMed ID: 16936297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.